Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, General Medicine,

Slides:



Advertisements
Similar presentations
Hollie Shaner-McRae DNP RN FAAN
Advertisements

Surgical Infection Prevention Project Team: Anesthesia Infectious Disease Pharmacy Surgical Services Labor & Delivery Quality Resource Management Center.
Optimizing Venous Thromboembolism Prophylaxis using Physician Order Entry: Johns Hopkins Hospital Experience Michael B. Streiff, MD Associate Professor.
Surgical Care Improvement Project - Pharmacy Process Improvement (Software) Mark Wong, Pharm.D., BCPS 1,2,3 ; George Melnik, Pharm.D., BCPS, 1,2 South.
Venous Thromboembolism Prevention August Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for.
Venous Thromboembolism Prophylaxis and Management in the Medical Patient at Sisters of Charity Hospital Jeffrey Parker, DO Dr. Nashat Rabadi, MD Sisters.
Prophylaxis of Venous Thromboembolism
Venous Thromboembolism (VTE) Prophylaxis Policy Mary-Anne Davies Patient Safety Specialist Accreditation Coordinator.
Deep Vein Thrombosis (DVT)
Perioperative Medicine Beyond Cardiac Clearance Pamela Pride MD July 31, 2012 MUSC.
RecommendationsRecommendations Risk Recommendation Ambulation (all pts) IPC/GCS or, UFH 5000 SQ q 12 hrs or, Enoxaparin 40mg SQ daily IPC/GCS or, UFH 5000.
Best Practices in Meeting NPSG 3E-Anticoagulation Requirements MaryAnne Cronin, PharmD Assistant Director of Pharmacy Glen Cove Hospital.
The Health Roundtable 3-3c_HRT1215-Session_HANNAFORD_UNSW_NSW How many people received appropriate VTE prophylaxis? Presenter: Natalie Hannaford UNSW Innovation.
VTE Prophylaxis Alert to providers and nursing Go live June 24, 2014.
DVT Prophylaxis in Medical Patients Rog Kyle, MD MUSC 6/5/12.
CMS Core Measures Evidence-Based Performance Measurement.
Carlos S. Morales, MD; Foula Kontonicolas MD; Anita Volpe DNP; Pierre F. Saldinger MD, FACS Royd Fukumoto, MD, FACS Department of Surgery and Department.
 When untreated, general postsurgical patients risk for Deep Venous Thrombosis (DVT) is 19%-25% (Buckner, et al., 2013).  Post surgical orthopedic patients.
Post OP Glucose Control For Cardiac Surgery The Society of Thoracic Surgeons Workforce guidelines (Lazar, 2009) recommended cardiac surgery patients, with.
Ferris State University Nursing Research Presented by: Rebecca Enright, Jiali Luc, Jenny Parish, Ashley Weststrate.
Venous Thromboembolism Safety Tool Kit Brenda K. Zierler, PhD, RN, RVT University of Washington Medication Safety: Tools for Diverse Settings September.
2007 Deep Vein Thrombosis (DVT) Awareness Program
Loyola University Chicago LOYOLA UNIVERSITY HEALTH SYSTEM Improving Care of Adult Patients Undergoing Cardiac Surgery LUMC CV-Surgical Team.
Postoperative venous thromboembolic disease prevention in the neurosurgery population Ahmad Khaldi, M.D. 1 Michael Wall, PharmD 2 T.C. Origitano, M.D.,
Prevention Of Venous Thromboembolism In The Cancer Surgical Patient A K Kakkar Barts and the London School of Medicine and Thrombosis Research Institute,
Venous Thromboembolism (VTE) Southern New Hampshire Medical Center Lynda Pittenger, RN, CPHQ Kathy Helberg, BSN,RN, CPHQ.
IMPLEMENTING GUIDELINES AND REDUCING PATIENT RISK OF VENOUS THROMBOEMBOLISM IN A LARGE UK TEACHING HOSPITAL Sharron Millen, Head of Clinical Pharmacy and.
Risk assessment for VTE
The Role of Thromboprophylaxis in Elective Spinal Surgery The Role of Thromboprophylaxis in Elective Spinal Surgery VA Elwell, N Koo Ng, D Horner & D Peterson.
Making Surgery Safer: Making Surgery Safer: Surgical Infection Prevention Team Members: Anesthesia: W. Scott Jellish – chair, Maureen Kawka Infectious.
Girish R. Mood, MD, Heather L. Gornik, MD, MHS, Vidyasagar Kalahasti, MD, Donald Hammer, MD, W. H. Wilson Tang, MD, FAHA. High Incidence of Venous Thrombosis.
Preventing Hospital Acquired Thrombosis Simon Noble Peggy Edwards.
LIFEBLOOD THE Thrombosis CHARITY LIFEBLOOD THE Thrombosis CHARITY NICE Clinical Guideline 46.
Rivaroxaban for Prevention of Venous Thromboembolism After Total Knee Arthroplasty: Impact on Healthcare Costs Based on the RECORD3 Study Kwong L, Lees.
VTE prevention and anticoagulation practice VTE prevention and anticoagulation practice Mr A McSorley Lead Thrombosis Nurse RCHT.
Venous Thromboembolism Prophylaxis for Medical Inpatients Heather Hofmann, rev. 4/18/14 DSR2 Mini Lecture.
Surgical Infection Prevention Team Members: Anesthesia: W. Scott Jellish - chair, Maureen Kawka, Joe Rinehart Infectious Disease: Paul O’Keefe, Chris Schriever.
Cost-Consciousness Assignment Ollie Ross DSR 2. Adherence to ACP DVT prophylaxis guidelines Objective: Evaluate adherence to ACP DVT prophylaxis guidelines.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, General Medicine,
Standardization of Weaning Practices for Adult Ventilator Patients Multidisciplinary Task Force Committee: Critical Care Services (Anesthesiology, Pulmonary,
Preventing Surgical Infections Through Effective Perioperative Antibiotic Administration Project Team Members: Anesthesia Infectious Disease Pharmacy Surgical.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, Pharmacy, CCE Confidential:
Quality and Patient Safety Council May 27, 2014 Presented By Susan M. Blackhurst BS, RN & Eric Jean BSN, RN, CCRN.
Peri-Operative anticoagulation /antiplatelet therapy A Shift in Paradigm BMHGT04/29/09.
Confidential: Quality Improvement Material Reducing Clotting Events for Post-Surgical Orthopedic Patients Loyola Anticoagulation Clinic Spring 2009.
Making Surgery Safer: Surgical Infection Prevention Team Members: Anesthesia: W. Scott Jellish- chair, Maureen Kawka, Nicole Wakim Infectious Disease:
SANOFI-SYNTHELABOARIXTRA ® 1 ARIXTRA ® (fondaparinux sodium) in the prevention of venous thromboembolism after hip replacement surgery KA Bauer, BI Eriksson,
Girish R. Mood, MD, Heather L. Gornik, MD, MHS, Vidyasagar Kalahasti, MD, Donald Hammer, MD, W. H. Wilson Tang, MD, FAHA. High Incidence of Venous Thrombosis.
Guide Available for Deep Vein Thrombosis Developed from Partnerships in Implementing Patient Safety program toolkit Developed from Partnerships in Implementing.
Orthopaedic Thromboprophylaxis: Experience from Derriford Hospital
Fundamental Research in Oncology & Thrombosis FRONTLINE 1 Survey.
Venous Thromboembolic (VTE) Prophylaxis in Pediatric Trauma Patients Bowe.
Dr Thomas Lloyd F1 Dr Aman Hargehandewal Wrexham Maelor Hospital
‘Preventing and treating blood clots’ The South Tees Anticoagulation Team 1.
Conclusions Results Methods Background Venous thrombo-embolism in patients undergoing neo- adjuvant chemotherapy and surgery for oesophago-gastric cancer.
Checklist overlap: Prevention of Surgical Site Infection and Venous Thromboembolism Marlies van Dijk, Western Node Leader Safer Healthcare Now! Safe Surgery.
Dr. Lesbia Adalgisa Rodriguez PGY3-Cook County Loyola Family Medicine Residency Program Venous Thromboembolism Prophylaxis in the Inpatient Setting.
Spotlight Case January 2006 An Ounce of Prevention.
What Is Deep Vein Thrombosis (DVT)? DVT is a blood clot that forms in a vein deep in the body Most often occurs in the deep veins of the legs, either.
Making Surgery Safer: Preventing Post Operative Myocardial Infarction Departments: Anesthesia, Cardiology, General Surgery, Orthopaedics, Primary Care,
Venous Thromboembolism Prophylaxis (VTE)
UNDERSTANDING YOUR RISK FOR DEVELOPING BLOOD CLOTS (VTE) IN CANCER
Dr.H.Chandrashekar, Dr.A.Chaudhuri, Dr. A. Douglas, Dr. D. Lowdon
UNDERSTANDING YOUR RISK FOR DEVELOPING BLOOD CLOTS (VTE) IN CANCER
Making Surgery Safer: Preventing Post Operative Myocardial Infarctions
The Burden of Hospital-Associated Venous Thromboembolism
Don't look now! Risk stratify first
Project Team: Anesthesia Infectious Disease Pharmacy Surgical Services
Preventing Venous Thromboembolism Participating Hospital Survey
Presentation transcript:

Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, General Medicine, Pharmacy, CCE

Opportunity Statement Venous thromboembolism (VTE- deep vein thrombosis and pulmonary embolism) is the most common preventable cause of death following surgery. The rate of post-operative VTE at LUMC (2-3%) is at the 90 th percentile compared to other Academic Medical Centers (UHC data)

Project Goals Achieve a 50% reduction in the occurrence rate of post-operative venous thromboembolism

Most Likely Causes for Current Opportunity Surgical patients are not routinely assessed and stratified for VTE risk Wide variability in use of prophylactic methods Variable awareness of national, evidence-based guidelines* Under utilization of pharmacologic prophylaxis (heparin) * Geerts, WH et al. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:338s-400s.

Solutions Implemented Developed and piloted Risk Assessment Tool in the Department of Surgery Developed guideline for selection of appropriate VTE prophylaxis for surgical patients Revised current standing post-operative orders in the Department of Surgery, Orthopaedics and Neurosurgery to include heparin or enoxaparin.

Next Steps Ongoing monitoring of risk assessment tool use Continued education of physicians and nursing staff Continue comparison with UHC data